2 156 kr
Läs direkt efter köp
2 156 kr
Läs direkt efter köp
1 858 kr
Skickas inom 11-20 vardagar
2 476 kr
Läs direkt efter köp
1 687 kr
Skickas inom 10-15 vardagar
1 127 kr
Skickas inom 10-15 vardagar
1 239 kr
Skickas inom 10-15 vardagar
567 kr
Skickas inom 10-15 vardagar
755 kr
Läs direkt efter köp
1 371 kr
Skickas inom 11-20 vardagar
This book focuses on putting successful molecular strategies into practice for the treatment of gynecologic cancer. It approaches research into the pathology and treatment of gynecologic oncology from both clinical and experimental perspectives. New insights made possible by the introduction of advanced technologies into the field are presented. This new volume will be necessary reading for clinicians and experimental researchers alike.
567 kr
Skickas inom 10-15 vardagar
1 687 kr
Skickas inom 10-15 vardagar
2 127 kr
Läs direkt efter köp
1 492 kr
Läs direkt efter köp
1 565 kr
Läs direkt efter köp
Molecular Pathology of Gynecologic Cancer focuses on putting successful molecular strategies into practice for the treatment of gynecologic cancer. The volume begins with an explication of the editors’ hypothesis that cancer is mainly a disease of the cell cycle, based on the deregulation of the physiological process of cell reproduction. The following eleven chapters focus on specific issues in gynecologic cancers, including: a proposed model of ovarian serous carcinogenesis, molecular markers for ovarian epithelial cancer, an overview of the pathology of endometrial cancer, molecular genetic aspects of endometrial carcinoma and cervical cancer, a natural history of Human Papilloma Virus (HPV) as it relates to cervical cancer, and hereditary issues in gynecologic cancers. The concluding chapter proposes and outlines a holistic approach to the treatment of female cancer patients. This new volume in Humana’s Current Clinical Oncology™ series will be necessary reading for clinicians and experimental researchers alike.
1 668 kr
Skickas inom 10-15 vardagar
1 659 kr
Läs direkt efter köp
1 668 kr
Skickas inom 10-15 vardagar
2 174 kr
Läs direkt efter köp
Breast Cancer is the most common tumor in women and the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Antonio Giordano, Nicola Normanno, and a panel of international authorities in their field provide a comprehensive approach to the biology, diagnosis, prevention, and treatment of human breast carcinoma.
The book provides a comprehensive approach to breast cancer, describing the use of gene profiling techniques to distinguish specific features of individual carcinomas, as well as emerging novel therapeutic approaches to treatment. Additional chapters cover the use of transgenic mice to model human breast cancer and the role of the EGF-CFC family in mammary gland development and neoplasia. Breast Cancer in the Post Genomic-Era succeeds in looking at breast cancer pathogenesis, diagnosis, and treatment under a more comprehensive light, and is a valuable resource for any Radiation or Surgical Oncologist, Cancer Biologist or Pathologist.
1 229 kr
Skickas inom 7-10 vardagar
1 687 kr
Skickas inom 10-15 vardagar
1 127 kr
Skickas inom 10-15 vardagar
1 350 kr
Skickas inom 10-15 vardagar
1 780 kr
Läs direkt efter köp
1 350 kr
Skickas inom 10-15 vardagar
1 014 kr
Skickas inom 10-15 vardagar
1 575 kr
Skickas inom 10-15 vardagar
1 502 kr
Läs direkt efter köp
1 127 kr
Skickas inom 10-15 vardagar
1 123 kr
Skickas inom 10-15 vardagar
1 502 kr
Läs direkt efter köp
This text properly considers the most recent and relevant advances in molecular RB of GB, taking into account the related topics of pathobiology, and underscores the most promising translational perspectives from the preclinical to the clinical domain. Section I (From Bedside to Bench) discusses conditions associated with RT resistance of GB and the consequent RB hints, technology improvements intended to overcome RT-resistance of GB, mathematical modeling of RB parameters from clinical studies, the present impact of molecular prognostic factors in therapy of GB, and RT tolerance of normal brain. Section II (Preclinical Research and Pathobiology Topics) presents the traditional and mechanistic/molecular approaches to RB of GB, genetic and epigenetic studies on GB, issues of cell-death pathways, stem-like cells, invasiveness, tumor microenvironment, hypoxia, mi-RNA manipulations, and nanoparticle technology. Section III (Translational Perspectives) presents RB issues related to molecular profiling and classification of GB as frames of reference for clinical studies, translational perspectives of gene therapy, evolving protocols based on pre-clinical data and large data-bases and ontologic models.
Radiobiology of Glioblastoma: Recent Advances and Related Pathobiology will be of great value to pathologists, medical oncologists, radiation oncologists as well as basic researchers and clinical investigators.